Latest Press Releases
![ivWatch Enters Into Licensing and Distribution Agreement With Terumo to Help Improve Patient Safety](https://cdn.nwe.io/files/x/0d/89/189cbd5cb1890bc69029b84e781d.jpg)
Terumo Corp., exclusive distributor for ivWatch in Japan, licenses ivWatch infiltration detection technology for use in products globally
![ivWatch Achieves ISO 13485 Certification: Provides Foundation for International Distribution](https://cdn.nwe.io/files/x/47/e9/67dc2df5b34a2e31f6e61dcf6b5d.jpg)
![ivWatch Launches OEM Solution, Expands Executive Team to Support Global Sales and Partnerships](https://cdn.nwe.io/files/x/9a/4d/9446a4674753a32170642313562a.jpg)
![ivWatch Honored as Finalist in the 2017 Medical Design Excellence Awards (MDEA)](https://cdn.nwe.io/files/x/04/8b/04deb0d1284fca3e0d27c6447296.jpg)
![ivWatch Receives FDA 510 (K) Clearance to Significantly Advance the Safety of IV Therapy for Pediatric Patients](https://cdn.nwe.io/files/x/b2/a9/0f5f441d9dfdb3057a63f224f03a.jpg)
New indication allows for wide scale implementation to help protect children across the United States
![ivWatch Participates in the World Pediatric Project Recent Mission to St. Vincent and the Grenadines](https://cdn.nwe.io/files/x/fd/21/d25b306cdcb1ab119b5d155514d9.jpg)
![ivWatch, LLC Announces Availability of a New Medical Device to Continuously Monitor IVs](https://cdn.nwe.io/files/x/6a/30/a29e86ebb77f7206fed783e58dd8.jpg)
The ivWatch Model 400 will improve patient safety through early detection of IV infiltrations and extravasations and provide a new option for IV therapy.